DE3110817A1 - Isoxazolderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel - Google Patents

Isoxazolderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel

Info

Publication number
DE3110817A1
DE3110817A1 DE19813110817 DE3110817A DE3110817A1 DE 3110817 A1 DE3110817 A1 DE 3110817A1 DE 19813110817 DE19813110817 DE 19813110817 DE 3110817 A DE3110817 A DE 3110817A DE 3110817 A1 DE3110817 A1 DE 3110817A1
Authority
DE
Germany
Prior art keywords
radical
general formula
isoxazole derivatives
carbon atoms
isoxazole
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
DE19813110817
Other languages
German (de)
English (en)
Inventor
Rezsö Dr. Bognár
István Pelyvás Dipl.-Chem. Dr. Ferenczik
Zoltán Dipl.-Chem. Dr. Györgydeák
József Dr. Debrecen Szegi
Ferenc Dipl.-Chem. Dr. Sztaricskei
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Egyt Gyogyszervegyeszeti Gyar
Original Assignee
Egyt Gyogyszervegyeszeti Gyar
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Egyt Gyogyszervegyeszeti Gyar filed Critical Egyt Gyogyszervegyeszeti Gyar
Publication of DE3110817A1 publication Critical patent/DE3110817A1/de
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
    • C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
    • C07D261/10—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
    • C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
    • C07D261/10—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D261/18—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Cardiology (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
DE19813110817 1980-03-19 1981-03-19 Isoxazolderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel Withdrawn DE3110817A1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU8080637A HU180567B (en) 1980-03-19 1980-03-19 Method for producing derivatives of isooxazole

Publications (1)

Publication Number Publication Date
DE3110817A1 true DE3110817A1 (de) 1982-03-04

Family

ID=10950573

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19813110817 Withdrawn DE3110817A1 (de) 1980-03-19 1981-03-19 Isoxazolderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel

Country Status (15)

Country Link
JP (1) JPS56158774A (sv)
BE (1) BE887954A (sv)
CA (1) CA1163631A (sv)
CH (1) CH646157A5 (sv)
DE (1) DE3110817A1 (sv)
DK (3) DK151012C (sv)
ES (3) ES8302674A1 (sv)
FI (1) FI70011C (sv)
FR (1) FR2478634A1 (sv)
GB (1) GB2075009B (sv)
HU (1) HU180567B (sv)
IT (1) IT1211010B (sv)
SE (1) SE454695B (sv)
SU (3) SU1053750A3 (sv)
YU (1) YU42560B (sv)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6100260A (en) * 1997-04-21 2000-08-08 Sumitomo Pharmaceutical Company, Limited Isoxazole derivatives
WO1998047880A1 (en) * 1997-04-21 1998-10-29 Sumitomo Pharmaceuticals Company, Limited Isoxazole derivatives

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL302496A (sv) * 1962-12-22
US3808221A (en) * 1971-04-14 1974-04-30 Hoffmann La Roche Antiandrogenic n-(3,5-dilower alkyl-4-heterocyclic)methyl)phthalimides

Also Published As

Publication number Publication date
IT1211010B (it) 1989-09-29
FI70011B (fi) 1986-01-31
DK153549B (da) 1988-07-25
DK23187A (da) 1987-01-16
FR2478634B1 (sv) 1983-11-10
DK23087A (da) 1987-01-16
SE454695B (sv) 1988-05-24
YU68981A (en) 1983-10-31
CH646157A5 (en) 1984-11-15
SU1053750A3 (ru) 1983-11-07
DK122581A (da) 1981-09-20
ES501095A0 (es) 1983-02-16
DK153549C (da) 1988-12-05
SU1152518A3 (ru) 1985-04-23
HU180567B (en) 1983-03-28
GB2075009B (en) 1983-11-30
DK151959C (da) 1988-07-11
ES8305340A1 (es) 1983-05-01
DK151959B (da) 1988-01-18
YU42560B (en) 1988-10-31
ES511895A0 (es) 1983-05-01
CA1163631A (en) 1984-03-13
GB2075009A (en) 1981-11-11
JPS56158774A (en) 1981-12-07
DK151012B (da) 1987-10-12
ES511894A0 (es) 1984-01-01
SU1158044A3 (ru) 1985-05-23
FI810838L (fi) 1981-09-20
BE887954A (fr) 1981-09-16
IT8120395A0 (it) 1981-03-18
SE8101703L (sv) 1981-09-20
DK151012C (da) 1988-07-04
FR2478634A1 (fr) 1981-09-25
ES8401758A1 (es) 1984-01-01
ES8302674A1 (es) 1983-02-16
FI70011C (fi) 1986-09-12

Similar Documents

Publication Publication Date Title
DE2901181C2 (de) N-(1-Alkyl- bzw. Allyl-2-pyrrolidinylmethyl)-2-methoxy-4-amino-5-alkylsulfonylbenzamide, deren Salze, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel
DE2618999C2 (de) 1-{[5-(4-Hydroxy-2H-1,2-benzothiazin-3-yl)-1,2.4-oxadiazol-3-yl]methyl}-äthanon-S,S-dioxide, Verfahren zu ihrer Herstellung sowie Verfahren zu ihrer Weiterverarbeitung
DE2733291A1 (de) (3-amino-5-substituiert-6-fluorpyrazinoyl- oder -pyrazinamido)-guanidine und ihre an den guanidino-stickstoffatomen substituierten derivate
DE2533821A1 (de) Thiazolidinderivate und verfahren zu ihrer herstellung
DE2347015C2 (de) Neue Pyrazolyloxyessigsäurederivate, Verfahren zu ihrer Herstellung und diese enthaltende Mittel
DE2362754A1 (de) Cyclopropylmethylamine, verfahren zu deren herstellung und diese verbindungen enthaltende arzneimittel
DE3110817A1 (de) Isoxazolderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
DE2413610A1 (de) Neue heterocyclische verbindungen und verfahren zu deren herstellung
DE3642497A1 (de) Substituierte aminopropionsaeureamide, verfahren zu ihrer herstellung, diese enthaltende mittel und ihre verwendung sowie die bei der herstellung anfallenden neuen zwischenprodukte
DE2841644A1 (de) 3(tetrazol-5-yl)-1-azaxanthone, verfahren zu ihrer herstellung und sie enthaltende arzneimittel
DE2453083A1 (de) Substituierte thiazol-2-carbonsaeureamidderivate und ihre salze sowie ihre verwendung und verfahren zur herstellung derselben
DD258812A1 (de) Verfahren zur herstellung neuer ixoxazolderivate
DE1695638A1 (de) 5-[(Aryldehydropiperidyl- und Aryldehydropyrrolidyl)-niederes alkyl]-2-oxazolidinone,sowie deren Herstellung
DE2815442A1 (de) Rasch wirksame diuretika
DE2131330A1 (de) Imidazo-[1,2-a]-benzimidazolderivate und Verfahren zur Herstellung derselben
DE2513136A1 (de) Aromatische amide heterocyclischer verbindungen
DE3204074C2 (sv)
DD299058A5 (de) Verfahren zur herstellung von n-acyl-4-phenyl-pyrrolidin-2-onen mit cerebroprotektiver wirkung
DE2114441A1 (de) Benzodiazepindenvate und Ver fahren zu ihrer Herstellung
DE2029991C3 (de) 2-Hydroxy-5-aminobenzamide, Verfahren zu ihrer Herstellung und Arzneimittel, die diese Verbindungen enthalten
EP0433218B1 (de) Verfahren zur Herstellung von Aminotriazinderivaten
DE2605824B2 (de) N-Acylaniline, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende pharmazeutische Zubereitungen
EP0215380A1 (de) 1,4-Disubstituierte Pyrazolderivate
AT309449B (de) Verfahren zur Herstellung von neuen Benzodiazepinderivats und dessen Säureadditionssalzen
LU81704A1 (de) Verfahren zur herstellung von 1,2,3-thiadiazol-5-yl-harnstoffen

Legal Events

Date Code Title Description
8110 Request for examination paragraph 44
8130 Withdrawal